Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2013

01.10.2013 | Colorectal Cancer

Early Outcomes for Rectal Cancer Surgery in the Republic of Ireland Following a National Centralization Program

verfasst von: John P. Burke, PhD, MRCSI, J. Calvin Coffey, PhD, FRCSI, Emily Boyle, MD, MRCSI, Frank Keane, MCh, FRCSI, Deborah A. McNamara, MD, FRCSI

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Following a national audit of rectal cancer management in 2007, a national centralization program in the Republic of Ireland was initiated. In 2010, a prospective evaluation of rectal cancer treatment and early outcomes was conducted.

Methods

A total of 29 colorectal surgeons in 14 centers prospectively collated data on all patients with rectal cancer who underwent curative surgery in 2010.

Results

Data were available on 447 patients who underwent proctectomy with curative intent for rectal cancer in 2010; 23.7 % of patients underwent abdominoperineal excision. The median number of lymph nodes identified was 12. The 30-day mortality rate was 1.1 %. Compared with 2007, there was a reduction in positive circumferential margin rate (15.8 vs 4.5 %, P < 0.001), clinical anastomotic leak rate (10.8 vs 4.3 %, P = 0.002), and postoperative radiotherapy use (17.8 vs 4.0 %, P < 0.001). Also, 53.9 % received preoperative radiotherapy in 2010. Four centers gave statistically more patients (high-administration), and four centers gave fewer patients (low-administration) preoperative radiotherapy for T2/T3 tumors (P < 0.05). On multivariate analysis, being treated in a “high-administration center” increased the likelihood (likelihood ratio [LR], 2.9; 95 % CI 1.7–4.8; P < 0.001) while attending a “low-administration center” (LR, 0.3; 95 % CI 0.2–0.5; P < 0.001) reduced the likelihood of receiving preoperative radiotherapy for a T2/T3 rectal cancer.

Conclusions

Patients undergoing rectal cancer surgery in hospitals following a national centralization initiative received high-quality surgery. Significant heterogeneity exists in radiotherapy administration, and evidence-based guidelines should be developed and implemented.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002;89:1142–9.PubMedCrossRef Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002;89:1142–9.PubMedCrossRef
2.
Zurück zum Zitat Kee F, Wilson RH, Harper C, Patterson CC, McCallion K, Houston RF, et al. Influence of hospital and clinician workload on survival from colorectal cancer: cohort study. BMJ. 1999;318:1381–5.PubMedCrossRef Kee F, Wilson RH, Harper C, Patterson CC, McCallion K, Houston RF, et al. Influence of hospital and clinician workload on survival from colorectal cancer: cohort study. BMJ. 1999;318:1381–5.PubMedCrossRef
4.
Zurück zum Zitat Boyle E, Timmons A, Al-Akash M, Kennedy AM, O’Grady H, Hill AD, et al. The management of rectal cancer in Ireland in 2007–room for improvement? Surgeon. 2011;9:179–86.PubMedCrossRef Boyle E, Timmons A, Al-Akash M, Kennedy AM, O’Grady H, Hill AD, et al. The management of rectal cancer in Ireland in 2007–room for improvement? Surgeon. 2011;9:179–86.PubMedCrossRef
5.
Zurück zum Zitat Archampong D, Borowski DW, Dickinson HO. Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon. 2010;8:341–52.PubMedCrossRef Archampong D, Borowski DW, Dickinson HO. Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon. 2010;8:341–52.PubMedCrossRef
6.
Zurück zum Zitat Hogan AM, Kennelly R, Winter DC. Volume-outcome analysis in rectal cancer: a plea for enquiry, evidence and evolution. Eur J Surg Oncol. 2009;35:111–2.PubMedCrossRef Hogan AM, Kennelly R, Winter DC. Volume-outcome analysis in rectal cancer: a plea for enquiry, evidence and evolution. Eur J Surg Oncol. 2009;35:111–2.PubMedCrossRef
7.
Zurück zum Zitat Elferink MA, Krijnen P, Wouters MW, Lemmens VE, Jansen-Landheer ML, van de Velde CJ, et al. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol. 2010;36 Suppl 1:S74–82.PubMedCrossRef Elferink MA, Krijnen P, Wouters MW, Lemmens VE, Jansen-Landheer ML, van de Velde CJ, et al. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol. 2010;36 Suppl 1:S74–82.PubMedCrossRef
8.
Zurück zum Zitat Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.PubMedCrossRef Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.PubMedCrossRef
9.
Zurück zum Zitat Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811–20.PubMedCrossRef Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811–20.PubMedCrossRef
10.
Zurück zum Zitat Simunovic M, Jacob S, Coates AJ, Vogt K, Moran BJ, Heald RJ, et al. Outcomes following a limited approach to radiotherapy in rectal cancer. Br J Surg. 2011;98:1483–8.PubMedCrossRef Simunovic M, Jacob S, Coates AJ, Vogt K, Moran BJ, Heald RJ, et al. Outcomes following a limited approach to radiotherapy in rectal cancer. Br J Surg. 2011;98:1483–8.PubMedCrossRef
11.
Zurück zum Zitat Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253:711–9.PubMedCrossRef Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253:711–9.PubMedCrossRef
12.
Zurück zum Zitat Gagliardi G, Pucciarelli S, Asteria CR, Infantino A, Romano G, Cola B, et al. A nationwide audit of the use of radiotherapy for rectal cancer in Italy. Tech Coloproctol. 2010;14:229–35.PubMedCrossRef Gagliardi G, Pucciarelli S, Asteria CR, Infantino A, Romano G, Cola B, et al. A nationwide audit of the use of radiotherapy for rectal cancer in Italy. Tech Coloproctol. 2010;14:229–35.PubMedCrossRef
13.
Zurück zum Zitat Mroczkowski P, Ortiz H, Penninckx F, Påhlman L. European quality assurance programme in rectal cancer—are we ready to launch? Colorectal Dis. 2012;14:960–6.PubMedCrossRef Mroczkowski P, Ortiz H, Penninckx F, Påhlman L. European quality assurance programme in rectal cancer—are we ready to launch? Colorectal Dis. 2012;14:960–6.PubMedCrossRef
14.
Zurück zum Zitat MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779.CrossRef MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779.CrossRef
15.
Zurück zum Zitat Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479–82.PubMedCrossRef Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479–82.PubMedCrossRef
16.
Zurück zum Zitat Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996–9.PubMedCrossRef Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996–9.PubMedCrossRef
17.
Zurück zum Zitat Royal College of Radiologists. Recommendations for Cross-Sectional Imaging in Cancer Management. London: Royal College of Radiologists; 2006. Royal College of Radiologists. Recommendations for Cross-Sectional Imaging in Cancer Management. London: Royal College of Radiologists; 2006.
18.
Zurück zum Zitat Association of Coloproctology of Great Britain and Ireland. Guidelines for the Management of Colorectal Cancer. 3rd ed. London: Association of Coloproctology of Great Britain and Ireland; 2007. Association of Coloproctology of Great Britain and Ireland. Guidelines for the Management of Colorectal Cancer. 3rd ed. London: Association of Coloproctology of Great Britain and Ireland; 2007.
19.
Zurück zum Zitat Archampong D, Borowski D, Wille-Jorgensen P, Iversen LH. Workload and surgeon s specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev. 2012;3:CD005391.PubMed Archampong D, Borowski D, Wille-Jorgensen P, Iversen LH. Workload and surgeon s specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev. 2012;3:CD005391.PubMed
20.
Zurück zum Zitat Killeen SD, O’Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg. 2005;92:389–402.PubMedCrossRef Killeen SD, O’Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg. 2005;92:389–402.PubMedCrossRef
21.
Zurück zum Zitat Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356:93–6.PubMedCrossRef Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356:93–6.PubMedCrossRef
22.
Zurück zum Zitat Leonard D, Penninckx F, Fieuws S, Jouret-Mourin A, Sempoux C, Jehaes C, et al. Factors predicting the quality of total mesorectal excision for rectal cancer. Ann Surg. 2010;252:982–8.PubMedCrossRef Leonard D, Penninckx F, Fieuws S, Jouret-Mourin A, Sempoux C, Jehaes C, et al. Factors predicting the quality of total mesorectal excision for rectal cancer. Ann Surg. 2010;252:982–8.PubMedCrossRef
23.
Zurück zum Zitat Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P; Dutch Colorectal Cancer Group; Pathology Review Committee. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257–64.PubMedCrossRef Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P; Dutch Colorectal Cancer Group; Pathology Review Committee. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257–64.PubMedCrossRef
24.
Zurück zum Zitat Marr R, Birbeck K, Garvican J, Macklin CP, Tiffin NJ, Parsons WJ, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74–82.PubMedCrossRef Marr R, Birbeck K, Garvican J, Macklin CP, Tiffin NJ, Parsons WJ, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74–82.PubMedCrossRef
25.
Zurück zum Zitat West NP, Anderin C, Smith KJ, Holm T, Quirke P; European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg. 2010;97:588–99.PubMedCrossRef West NP, Anderin C, Smith KJ, Holm T, Quirke P; European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg. 2010;97:588–99.PubMedCrossRef
26.
Zurück zum Zitat Govindarajan A, Gonen M, Weiser MR, Shia J, Temple LK, Guillem JG, et al. Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol. 2011;29:4568–73.PubMedCrossRef Govindarajan A, Gonen M, Weiser MR, Shia J, Temple LK, Guillem JG, et al. Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol. 2011;29:4568–73.PubMedCrossRef
27.
Zurück zum Zitat Craven I, Crellin A, Cooper R, Melcher A, Byrne P, Sebag-Montefiore D. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer. 2007;97:1333–7.PubMedCrossRef Craven I, Crellin A, Cooper R, Melcher A, Byrne P, Sebag-Montefiore D. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer. 2007;97:1333–7.PubMedCrossRef
28.
Zurück zum Zitat Benzoni E, Terrosu G, Intersimone D, Milan E, Chiaulon G, Bresadola V, et al. Instrumental clinical restaging, pathological evaluation, and tumor regression grading: how to assess the response to neoadjuvant chemoradiotherapy for rectal cancer. Int J Colorectal Dis. 2007;22:7–13.PubMedCrossRef Benzoni E, Terrosu G, Intersimone D, Milan E, Chiaulon G, Bresadola V, et al. Instrumental clinical restaging, pathological evaluation, and tumor regression grading: how to assess the response to neoadjuvant chemoradiotherapy for rectal cancer. Int J Colorectal Dis. 2007;22:7–13.PubMedCrossRef
29.
Zurück zum Zitat Caudle AS, Kim HJ, Tepper JE, O’Neil BH, Lange LA, Goldberg RM, et al. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer. Ann Surg Oncol. 2008;15:1931–6.PubMedCrossRef Caudle AS, Kim HJ, Tepper JE, O’Neil BH, Lange LA, Goldberg RM, et al. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer. Ann Surg Oncol. 2008;15:1931–6.PubMedCrossRef
30.
Zurück zum Zitat Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19:2212–23.PubMedCrossRef Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19:2212–23.PubMedCrossRef
31.
Zurück zum Zitat Gunderson LL, Callister M, Marschke R, Young-Fadok T, Heppell J, Efron J. Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status. Gastrointest Cancer Res. 2008;2:25–33.PubMed Gunderson LL, Callister M, Marschke R, Young-Fadok T, Heppell J, Efron J. Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status. Gastrointest Cancer Res. 2008;2:25–33.PubMed
32.
Zurück zum Zitat Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.PubMedCrossRef Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.PubMedCrossRef
33.
Zurück zum Zitat Srinivasaiah N, Monson JR. Radiotherapy in rectal cancer: is it time for change? A qualitative analysis of the national questionnaire survey of members of ACPGBI on preliminary CRO7 results. Colorectal Dis. 2008;10:873–8.PubMedCrossRef Srinivasaiah N, Monson JR. Radiotherapy in rectal cancer: is it time for change? A qualitative analysis of the national questionnaire survey of members of ACPGBI on preliminary CRO7 results. Colorectal Dis. 2008;10:873–8.PubMedCrossRef
34.
Zurück zum Zitat Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, et al. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol. 2006;24:361–9.PubMedCrossRef Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, et al. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol. 2006;24:361–9.PubMedCrossRef
Metadaten
Titel
Early Outcomes for Rectal Cancer Surgery in the Republic of Ireland Following a National Centralization Program
verfasst von
John P. Burke, PhD, MRCSI
J. Calvin Coffey, PhD, FRCSI
Emily Boyle, MD, MRCSI
Frank Keane, MCh, FRCSI
Deborah A. McNamara, MD, FRCSI
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2013
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-3131-2

Weitere Artikel der Ausgabe 11/2013

Annals of Surgical Oncology 11/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.